Hemodialysis Market to Grow at 4.5% CAGR, Crossing US$ 149.92 Billion by 2033 | Fact.MR

The hemodialysis market is expected to reach US$ 149.92 billion by 2033, from its estimated US$ 96.54 billion in 2023, according to a recent industry analysis by Fact.MR, a supplier of competitive intelligence and market research.

Dialysis is a process that removes waste products from the blood, like creatinine and urea, which are created when the kidneys don't work properly. For people with chronic renal disorders, dialysis is required. Hemodialysis is the process of pumping blood through vascular access points, purifying it with a dialyzer, and then reintroducing it to the body. Dialysis via hemodialysis is a treatment for kidney diseases.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8315

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲

From 2023 to 2033, the global market for hemodialysis products is projected to grow at a 4.5% compound annual growth rate.
Over the estimated period, the hemodialysis market in China is expected to grow at a high CAGR of 7%.
Over the next ten years, hemodialysis service demand is predicted to increase globally at a CAGR of 5%.
Over the course of the projected period, the Canadian market is expected to grow at a 4% CAGR.

"Product sales growth is being driven by the rapidly evolving medical industry, growing technology breakthroughs like automation, and an increase in the number of older people with specific conditions," says a Fact.MR analyst.

𝐑𝐞𝐜𝐞𝐧𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬

In March 2022, Nipro Medical Corporation launched the SURDIAL DX Hemodialysis System in the US. The goal of the system is to provide the greatest possible experience for both patients and healthcare providers during dialysis treatments.

In June 2021, Baxter International Inc. introduced Sharesource Analytics 1.0, a next-generation eHealth solution for dialysis patients receiving at-home treatment. This scientific advancement is a clinical management tool that is connected with the Sharesource remote patient monitoring system to give medical practitioners detailed information about how their patients receiving home dialysis are being cared for.

In December 2020, Medtronic unveiled a pediatric and newborn dialysis device in the US market.

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8315

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

Leading manufacturers' efforts to produce specialized dialysis equipment and the growing alliances and collaboration among industry participants are expected to propel the market. In order to increase the scope of their product offerings, several of the major companies in the hemodialysis market are partnering with regional players. To this aim, they are continuously refining their strategies regarding price trends, local supply chain management systems, and requirements for product quality.

𝐒𝐨𝐦𝐞 𝐍𝐞𝐰 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬

For example, in December 2020, Medtronic released its Carpediem Cardio-Renal Paediatric Dialysis Emergency Machine in the United States following FDA marketing approval. The first machine was donated to the Cincinnati Children's Hospital Medical Center.
As the dialysis industry grows, it has unmet technology needs. In October 2020, Diality committed approximately US$ 12.5 million to develop a portable hemodialysis system.
In order to improve the quality of life and outcomes for people with end-stage chronic kidney disease, Fresenius Medical Care North America (FMCNA) and Livongo Health, Inc. entered into a groundbreaking partnership in October 2020. This partnership aims to raise the optimal dialysis starts and provide earlier analysis of transplantation and home dialysis options.

𝐊𝐞𝐲 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐒𝐞𝐫𝐯𝐢𝐜𝐞 𝐏𝐫𝐨𝐯𝐢𝐝𝐞𝐫𝐬

Boston Scientific Corporation
Johnson and Johnson Services, Inc.
Pfizer, Inc.
Baxter International, Inc.
Amgen, Inc.
Novartis AG
F. Hoffmann La-Roche Ltd
Bayer AG.

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐨𝐟 𝐇𝐞𝐦𝐨𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

By Product :
Services
Drugs
Consumables
Equipment

By Modality :
Conventional Long-term Hemodialysis
Short Daily Hemodialysis
Nocturnal Hemodialysis

By End User :
Dialysis Centers
Hospitals
Home Care Settings

By Region :
North America
Latin America
Europe
East Asia
South Asia & Oceania
MEA

𝐌𝐨𝐫𝐞 𝐕𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐨𝐧 𝐎𝐟𝐟𝐞𝐫

With its latest product, Fact.MR offers a dispassionate evaluation of the worldwide hemodialysis industry, showcasing demand data from 2018 to 2022 as well as projections for 2023 to 2033.

Across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA), the study provides crucial insights into the market based on product (services, drugs, consumables, equipment), modality (conventional long-term hemodialysis, short daily hemodialysis, nocturnal hemodialysis), and end user (dialysis centers, hospitals, home care settings).

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.